101
|
Morita J, Aoyama T, Sugano N, Sato T, Amano S, Nagashima T, Ishikawa Y, Taguri M, Yamanaka T, Yamamoto Y, Oshima T, Yukawa N, Rino Y, Masuda M. Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx676.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
102
|
Sato T, Aoyama T, Maezawa Y, Kano K, Hayashi T, Yamada T, Oshima T, Rino Y, Ogata T, Cho H, Yoshikawa T, Masuda M. Impact of preoperative sarcopenia on overall survival in gastric cancer surgery. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
103
|
Hara K, Hayashi T, Osakabe H, Nakazono M, Nagasawa S, Kumazu Y, Yamada T, Rino Y, Masuda M, Ogata T, Yoshikawa T. Optimal cutoff of histological response by neoadjuvant chemotherapy for gastric cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
104
|
Dash N, Bahinipati S, Bhardwaj V, Trabelsi K, Adachi I, Aihara H, Al Said S, Asner DM, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Barberio E, Bhuyan B, Biswal J, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Breibeck F, Browder TE, Červenkov D, Chang MC, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Choi Y, Cinabro D, Di Carlo S, Doležal Z, Drásal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Gillard R, Goldenzweig P, Haba J, Hara T, Hayasaka K, Hayashii H, Hedges MT, Hou WS, Iijima T, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Jin Y, Joffe D, Joo KK, Julius T, Kahn J, Kaliyar AB, Karyan G, Katrenko P, Kawasaki T, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumar R, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li CH, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matvienko D, Merola M, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Mohanty S, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Pakhlov P, Pakhlova G, Pal B, Pardi S, Park CS, Park H, Paul S, Pedlar TK, Pesántez L, Pestotnik R, Piilonen LE, Prasanth K, Ritter M, Rostomyan A, Sahoo H, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Stypula J, Sumisawa K, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Tenchini F, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Usov Y, Van Hulse C, Varner G, Vorobyev V, Vossen A, Waheed E, Wang CH, Wang MZ, Wang P, Watanabe M, Watanabe Y, Widmann E, Williams KM, Won E, Yamashita Y, Ye H, Yelton J, Yook Y, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Search for CP Violation and Measurement of the Branching Fraction in the Decay D^{0}→K_{S}^{0}K_{S}^{0}. PHYSICAL REVIEW LETTERS 2017; 119:171801. [PMID: 29219447 DOI: 10.1103/physrevlett.119.171801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Indexed: 06/07/2023]
Abstract
We report a study of the decay D^{0}→K_{S}^{0}K_{S}^{0} using 921 fb^{-1} of data collected at or near the ϒ(4S) and ϒ(5S) resonances with the Belle detector at the KEKB asymmetric energy e^{+}e^{-} collider. The measured time-integrated CP asymmetry is A_{CP}(D^{0}→K_{S}^{0}K_{S}^{0})=(-0.02±1.53±0.02±0.17)%, and the branching fraction is B(D^{0}→K_{S}^{0}K_{S}^{0})=(1.321±0.023±0.036±0.044)×10^{-4}, where the first uncertainty is statistical, the second is systematic, and the third is due to the normalization mode (D^{0}→K_{S}^{0}π^{0}). These results are significantly more precise than previous measurements available for this mode. The A_{CP} measurement is consistent with the standard model expectation.
Collapse
|
105
|
Utsugisawa K, Nagane Y, Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M. Early fast-acting treatment strategy against generalized myasthenia gravis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
106
|
Imai K, Masuda M, Watanabe H, Kamagata K, Katahira K, Ogura A, Ohdake R, Kawabata K, Yokoi T, Hara K, Bagarinao E, Atsuta N, Nakamura R, Aoki S, Katsuno M, Ohira H, Sobue G. Decision making alteration and characteristic connectivity changes in amyotrophic lateral sclerosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
107
|
Sone J, Mori K, Haruki K, Nakamura T, Masuda M, Yoshida M, Iwasaki Y, Tanaka F, Katsuno M, Sobue G. Clinical presentation and diagnosis of neuronal intranuclear inclusion disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
108
|
Ogura A, Masuda M, Imai K, Ohdake R, Tanaka Y, Yokoi T, Kawabata K, Hara K, Nakamura R, Atsuta N, Watanabe H, Katsuno M, Sobue G. Characteristics of semantic impairment in ALS associated with jukujikun. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
109
|
Yokoi T, Watanabe H, Aya O, Kawabata K, Imai K, Hara K, Masuda M, Ohdake R, Yamaguchi H, Miyao S, Katsuno M, Okamura N, Yanai K, Sobue G. The spatial accumulation patterns in normal elderly using 18F-THK5351 pet. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
110
|
Tanaka S, Masuda M, Minowa Y, Ueta Y, Hirano T, Aizawa H. IL-6 attenuate the efficacy of treatment with glucocorticoid in the patients with myasthenia gravis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
111
|
Kanda T, Fujita M, Iida O, Masuda M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Sunaga A, Uematsu M, Mano T. P3367A novel index of left ventricular stiffness predicting clinical outcome in patients with heart failure. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
112
|
Okuno S, Ishihara T, Iida O, Fujita M, Masuda M, Okamoto S, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1387Three-year clinical outcomes of hemodialysis patients with coronary artery disease after second-generation drug-eluting stent implantation. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
113
|
Masuda M, Watanabe S, Tanaka M, Tanaka A, Araki H. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus. J Clin Pharm Ther 2017; 43:15-20. [DOI: 10.1111/jcpt.12595] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Accepted: 06/23/2017] [Indexed: 11/28/2022]
|
114
|
Masuda M, Yamada T. Signaling pathway profiling using reverse-phase protein array and its clinical applications. Expert Rev Proteomics 2017. [PMID: 28621158 DOI: 10.1080/14789450.2017.1344101] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
INTRODUCTION Increased accessibility to next-generation sequencing within the last decade has led to a paradigm shift in cancer treatment from one-size-fits-all medicine to precision medicine providing therapeutic strategies tailored to the requirements of individual patients. However, the effect of even the most successful agent yet tested is only transient, and durable efficacy has yet to be achieved. Genome- and transcriptome-based approaches cannot fully predict the diversity of protein expression patterns or post-translational modifications that directly contribute to cancer pathogenesis and physiology. This underscores the need for concordant proteomic analysis in the next stage of precision medicine. Areas covered: This review begins with an overview of the recent advances and trends in precision medicine that currently rely on genomics, and highlights the utility of antibody-based reverse-phase protein array (RPPA) technology as a proteomic tool in this context. Expert commentary: RPPA is well suited for pharmacodynamics analysis in view of its ability to precisely map signaling status using limited amounts of clinical samples. In addition, the cost-effectiveness and rapid turn-around time of the RPPA platform offer a substantial advantage over existing molecular profiling technologies in clinical settings.
Collapse
|
115
|
Hirose S, Iijima T, Adachi I, Adamczyk K, Aihara H, Al Said S, Asner DM, Atmacan H, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Barberio E, Behera P, Berger M, Bhuyan B, Biswal J, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chang P, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Choi Y, Cinabro D, Danilov M, Dash N, Di Carlo S, Dingfelder J, Doležal Z, Drásal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Goldenzweig P, Golob B, Greenwald D, Grygier J, Haba J, Hara K, Hasenbusch J, Hayasaka K, Hayashii H, Higuchi T, Hou WS, Hsu CL, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Jin Y, Joffe D, Joo KK, Julius T, Kato Y, Kawasaki T, Kichimi H, Kiesling C, Kim DY, Kim JB, Kim KT, Kim MJ, Kim SH, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumar R, Kwon YJ, Lange JS, Li CH, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, MacNaughton J, Masuda M, Matsuda T, Matvienko D, Miyabayashi K, Miyake H, Miyata H, Mizuk R, Mohanty GB, Moon HK, Mori T, Mussa R, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Ono H, Onuki Y, Ostrowicz W, Pakhlov P, Pakhlova G, Pal B, Park CW, Park H, Paul S, Pesántez L, Pestotnik R, Piilonen LE, Prasanth K, Ritter M, Rostomyan A, Rozanska M, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Seon O, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sokolov A, Solovieva E, Starič M, Strube JF, Sumisawa K, Sumiyoshi T, Takizawa M, Tamponi U, Tenchini F, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Ushiroda Y, Usov Y, Van Hulse C, Varner G, Varvell KE, Vossen A, Wang CH, Wang MZ, Wang P, Watanabe M, Watanabe Y, Widmann E, Won E, Yamashita Y, Ye H, Yelton J, Yuan CZ, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Measurement of the τ Lepton Polarization and R(D^{*}) in the Decay B[over ¯]→D^{*}τ^{-}ν[over ¯]_{τ}. PHYSICAL REVIEW LETTERS 2017; 118:211801. [PMID: 28598663 DOI: 10.1103/physrevlett.118.211801] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Indexed: 06/07/2023]
Abstract
We report the first measurement of the τ lepton polarization P_{τ}(D^{*}) in the decay B[over ¯]→D^{*}τ^{-}ν[over ¯]_{τ} as well as a new measurement of the ratio of the branching fractions R(D^{*})=B(B[over ¯]→D^{*}τ^{-}ν[over ¯]_{τ})/B(B[over ¯]→D^{*}ℓ^{-}ν[over ¯]_{ℓ}), where ℓ^{-} denotes an electron or a muon, and the τ is reconstructed in the modes τ^{-}→π^{-}ν_{τ} and τ^{-}→ρ^{-}ν_{τ}. We use the full data sample of 772×10^{6} BB[over ¯] pairs recorded with the Belle detector at the KEKB electron-positron collider. Our results, P_{τ}(D^{*})=-0.38±0.51(stat)_{-0.16}^{+0.21}(syst) and R(D^{*})=0.270±0.035(stat)_{-0.025}^{+0.028}(syst), are consistent with the theoretical predictions of the standard model.
Collapse
|
116
|
Kameta N, Matsuzawa T, Yaoi K, Fukuda J, Masuda M. Glycolipid-based nanostructures with thermal-phase transition behavior functioning as solubilizers and refolding accelerators for protein aggregates. SOFT MATTER 2017; 13:3084-3090. [PMID: 28361133 DOI: 10.1039/c7sm00310b] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The self-assembly of synthetic glycolipids produced nanostructures such as vesicles and nanotubes consisting of bilayer membranes, which underwent a gel-to-liquid crystalline thermal phase transition. Vesicles formed at temperatures above the thermal phase transition temperatures (Tg-l) could solubilize aggregates of denatured proteins by trapping them in the fluid bilayer membranes. Cooling to temperatures below Tg-l caused a morphological transformation into nanotubes that accompanied the thermal phase transition from the fluid to the solid state. This phenomenon allowed the trapped proteins to be quickly released into the bulk solution and simultaneously facilitated the refolding of the proteins. The refolding efficiency strongly depended on the electrostatic attraction between the bilayer membranes of the nanostructures and the proteins. Because of the long shape (>400 nm) of the nanotubes, simple membrane filtration through a pore size of 200 nm led to complete separation and recovery of the refolded proteins (3-9 nm sizes).
Collapse
|
117
|
Tomisawa R, Ikaga T, Kim K, Ohkoshi Y, Okada K, Masunaga H, Kanaya T, Masuda M, Maeda Y. Effect of draw ratio on fiber structure development of polyethylene terephthalate. POLYMER 2017. [DOI: 10.1016/j.polymer.2016.12.071] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
118
|
Yamada T, Masuda M. Emergence of TNIK inhibitors in cancer therapeutics. Cancer Sci 2017; 108:818-823. [PMID: 28208209 PMCID: PMC5448614 DOI: 10.1111/cas.13203] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Revised: 02/03/2017] [Accepted: 02/10/2017] [Indexed: 12/25/2022] Open
Abstract
The outcome of patients with metastatic colorectal cancer remains unsatisfactory. To improve patient prognosis, it will be necessary to identify new drug targets based on molecules that are essential for colorectal carcinogenesis, and to develop therapeutics that target such molecules. The great majority of colorectal cancers (>90%) have mutations in at least one Wnt signaling pathway gene. Aberrant activation of Wnt signaling is a major force driving colorectal carcinogenesis. Several therapeutics targeting Wnt pathway molecules, including porcupine, frizzled receptors and tankyrases, have been developed, but none of them have yet been incorporated into clinical practice. Wnt signaling is most frequently activated by loss of function of the adenomatous polyposis coli (APC) tumor suppressor gene. Restoration of APC gene function does not seem to be a realistic therapeutic approach, and, therefore, only Wnt signaling molecules downstream of the APC gene product can be considered as targets for pharmacological intervention. Traf2 and Nck‐interacting protein kinase (TNIK) was identified as a regulatory component of the β‐catenin and T‐cell factor‐4 (TCF‐4) transcriptional complex. Several small‐molecule compounds targeting this protein kinase have been shown to have anti‐tumor effects against various cancers. An anthelmintic agent, mebendazole, was recently identified as a selective inhibitor of TNIK and is under clinical evaluation. TNIK regulates Wnt signaling in the most downstream part of the pathway, and its pharmacological inhibition seems to be a promising therapeutic approach. We demonstrated the feasibility of this approach by developing a small‐molecule TNIK inhibitor, NCB‐0846.
Collapse
|
119
|
Wehle S, Niebuhr C, Yashchenko S, Adachi I, Aihara H, Al Said S, Asner DM, Aulchenko V, Aushev T, Ayad R, Aziz T, Babu V, Bakich AM, Bansal V, Barberio E, Bartel W, Behera P, Bhuyan B, Biswal J, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chang P, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Choi Y, Cinabro D, Dash N, Dingfelder J, Doležal Z, Drásal Z, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Gillard R, Goldenzweig P, Golob B, Grzymkowska O, Guido E, Haba J, Hara T, Hayasaka K, Hayashii H, Hedges MT, Hou WS, Hsu CL, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Jin Y, Joffe D, Joo KK, Julius T, Kaliyar AB, Kang KH, Karyan G, Katrenko P, Kawasaki T, Kichimi H, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim KT, Kim MJ, Kim SH, Kinoshita K, Koch L, Kodyš P, Korpar S, Kotchetkov D, Križan P, Krokovny P, Kuhr T, Kulasiri R, Kumita T, Kuzmin A, Kwon YJ, Lange JS, Li CH, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Miyabayashi K, Miyake H, Mizuk R, Mohanty GB, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Natkaniec Z, Nayak M, Nisar NK, Nishida S, Ogawa S, Ono H, Onuki Y, Pakhlova G, Pal B, Park CS, Park CW, Park H, Paul S, Pesántez L, Piilonen LE, Pulvermacher C, Rauch J, Ritter M, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Seon O, Seong IS, Sevior ME, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sinha R, Solovieva E, Starič M, Strube JF, Sumisawa K, Sumiyoshi T, Takizawa M, Tamponi U, Tenchini F, Trabelsi K, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Ushiroda Y, Usov Y, Vahsen SE, Van Hulse C, Varner G, Varvell KE, Vorobyev V, Vossen A, Waheed E, Wang CH, Wang MZ, Wang P, Watanabe M, Watanabe Y, Widmann E, Williams KM, Won E, Yamamoto H, Yamashita Y, Ye H, Yook Y, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Ziegler M, Zupanc A. Lepton-Flavor-Dependent Angular Analysis of B→K^{*}ℓ^{+}ℓ^{-}. PHYSICAL REVIEW LETTERS 2017; 118:111801. [PMID: 28368653 DOI: 10.1103/physrevlett.118.111801] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Indexed: 06/07/2023]
Abstract
We present a measurement of angular observables and a test of lepton flavor universality in the B→K^{*}ℓ^{+}ℓ^{-} decay, where ℓ is either e or μ. The analysis is performed on a data sample corresponding to an integrated luminosity of 711 fb^{-1} containing 772×10^{6} BB[over ¯] pairs, collected at the ϒ(4S) resonance with the Belle detector at the asymmetric-energy e^{+}e^{-} collider KEKB. The result is consistent with standard model (SM) expectations, where the largest discrepancy from a SM prediction is observed in the muon modes with a local significance of 2.6σ.
Collapse
|
120
|
Masuda M, Yamada T. The emergence of TNIK as a therapeutic target for colorectal cancer. Expert Opin Ther Targets 2017; 21:353-355. [DOI: 10.1080/14728222.2017.1297799] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
121
|
Nanut T, Zupanc A, Adachi I, Aihara H, Al Said S, Asner DM, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bakich AM, Bansal V, Behera P, Bhardwaj V, Biswal J, Bondar A, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chistov R, Cho K, Choi SK, Choi Y, Cinabro D, Dash N, Di Carlo S, Doležal Z, Dutta D, Eidelman S, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Garmash A, Gillard R, Goldenzweig P, Golob B, Hayasaka K, Hayashii H, Hou WS, Iijima T, Inami K, Inguglia G, Ishikawa A, Iwasaki Y, Jacobs WW, Jaegle I, Joffe D, Joo KK, Julius T, Kaliyar AB, Kang KH, Kawasaki T, Kim DY, Kim JB, Kim KT, Kim MJ, Kim SH, Kinoshita K, Kodyš P, Korpar S, Krokovny P, Kuhr T, Kulasiri R, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li CH, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Masuda M, Matsuda T, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moon HK, Nakao M, Nath KJ, Nayak M, Nisar NK, Nishida S, Ogawa S, Okuno S, Pakhlov P, Pakhlova G, Pal B, Park CS, Park CW, Park H, Paul S, Pedlar TK, Pesántez L, Pestotnik R, Petrič M, Piilonen LE, Prasanth K, Pulvermacher C, Rauch J, Ritter M, Rostomyan A, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Seon O, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Solovieva E, Stanič S, Starič M, Strube JF, Stypula J, Sumiyoshi T, Takizawa M, Tamponi U, Tenchini F, Trabelsi K, Uchida M, Uno S, Ushiroda Y, Varner G, Vinokurova A, Vorobyev V, Vossen A, Wang CH, Wang MZ, Wang P, Watanabe Y, Widmann E, Won E, Yamaoka J, Yamashita Y, Yelton J, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V. Observation of D^{0}→ρ^{0}γ and Search for CP Violation in Radiative Charm Decays. PHYSICAL REVIEW LETTERS 2017; 118:051801. [PMID: 28211706 DOI: 10.1103/physrevlett.118.051801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2016] [Indexed: 06/06/2023]
Abstract
We report the first observation of the radiative charm decay D^{0}→ρ^{0}γ and the first search for CP violation in decays D^{0}→ρ^{0}γ, ϕγ, and K[over ¯]^{*0}(892)γ, using a data sample of 943 fb^{-1} collected with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. The branching fraction is measured to be B(D^{0}→ρ^{0}γ)=(1.77±0.30±0.07)×10^{-5}, where the first uncertainty is statistical and the second is systematic. The obtained CP asymmetries A_{CP}(D^{0}→ρ^{0}γ)=+0.056±0.152±0.006, A_{CP}(D^{0}→ϕγ)=-0.094±0.066±0.001, and A_{CP}(D^{0}→K[over ¯]^{*0}γ)=-0.003±0.020±0.000 are consistent with no CP violation. We also present an improved measurement of the branching fractions B(D^{0}→ϕγ)=(2.76±0.19±0.10)×10^{-5} and B(D^{0}→K[over ¯]^{*0}γ)=(4.66±0.21±0.21)×10^{-4}.
Collapse
|
122
|
Uno Y, Moriyama H, Kashimoto S, Masuda M, Sawa M, Yamada T. A Novel TNIK inhibitor, N5355 potently induced apoptotic cell death through down-regulation of Wnt signaling. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32694-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
123
|
Kanda T, Borizanova A, Borizanova A, Zayat R, Bianco F, Hajdu M, Cherata DA, Ariani R, Sanchez J, Surkova E, Kalcik M, Demkina AE, Di Meglio M, Luszczak JM, Filipiak D, Sanz Sanchez J, Kolesnyk MY, Cersit S, Chokesuwattanaskul R, De Lepper AGW, Hubert A, Tavares Da Silva M, Svetlin Nedkov Tsonev ST, Ahmed A, Fujita M, Iida O, Masuda M, Okamoto S, Ishihara T, Nanto K, Uematsu M, Kinova E, Goudev A, Kinova E, Goudev A, Aljalloud A, Musetti G, Kang HJ, Jansen-Park SH, Goetzenich A, Autschbach R, Hatam N, Cicchitti V, Bucciarelli V, Di Girolamo E, Tonti G, De Caterina R, Gallina S, Vertes V, Meiszterics ZS, Szabados S, Simor T, Faludi R, Muraru D, Palermo C, Romeo G, Aruta P, Binotto G, Semenzato G, Carstea D, Iliceto S, Badano LP, Soesanto AM, Ruiz M, Mesa D, Delgado M, Gutierrez G, Aristizabal CH, Fernandez J, Ferreiro C, Duran E, Anguita M, Castillo JC, Pan M, Arizon JM, Suarez De Lezo J, Bidviene J, Brunello G, Veronesi F, Cavalli G, Sokalskis V, Aruta P, Badano LP, Muraru D, Yesin M, Bayam E, Gunduz S, Gursoy MO, Karakoyun S, Astarcioglu MA, Cersit S, Candan O, Ozkan M, Krylova NS, Poteshkina NG, Kovalevskaya EA, Hashieva FM, Venner C, Huttin O, Guillaumot A, Chaouat A, Chabot F, Juilliere Y, Selton-Suty C, Williams CA, Stuart AG, Pieles GE, Kasprzak JD, Lipiec P, Osa Saez A, Arnau Vives MA, Buendia Fuentes F, Ferre Valverdu M, Quesada Carmona A, Serrano Martinez F, Montero Argudo A, Martinez Dolz L, Rueda Soriano J, Nikitjuk OV, Dzyak GV, Gunduz S, Tabakci M, Gursoy O, Karakoyun S, Bayam E, Kalcik M, Yesin M, Ozkan M, Satitthummanid S, Boonyaratavej S, Herold IHF, Saporito S, Bouwman RA, Mischi M, Korsten HHM, Reesink KD, Houthuizen P, Galli E, Bouzille G, Samset E, Donal E, Pestana G, De Sousa C, Pinto R, Ribeiro V, Vasconcelos M, Almeida PB, Macedo F, Maciel MJ, Manov E, Runev N, Shabani R, Gartcheva M, Donova T, Petrov I, Al-Mallah M. HIT Poster session 1P161E/e'*SV is a better predictor of outcome than E/e' in patients with heart failure with preserved left ventricular ejection fractionP162Subclinical left atrial and left ventricular structural and functional abnormalities in postmenopausal women with abdominal obesityP163Central obesity and hypertension: double burden to the left atrium of postmenopausal womenP164Comparison between 3-D blood pressure pulse analyser and pulsed-wave doppler echocardiography derived hemodynamic parameters in cardiac surgery patients - a pilot studyP165Paced-induced heart electrical activation modifies the orientation of left ventricular flow momentum: novel insights from echocardiographic particle image velocimetryP166Correlations between echocardiographic and CMR-derived parameters of right ventricular size and function in patients with COPDP167Longitudinal strain analysis allows the identification of subclinical deterioration of right ventricular myocardial function in patients with cancer therapy-related left ventricular dysfunctionP168Effect of atrial fibrillation to pulmonary hypertension and right ventricular function in patient with severe mitral stenosisP169Evolution of etiologic spectrum and clinical features of mitral regurgitation since 2007 until 2015P170Tricuspid annulus area correlates more with right atrial than right ventricular volumes in patients with different mechanisms of functional tricuspid regurgitation: a 3D echocardiography studyP171The effect of hemolysis on serum lipid levels in patients suffering from severe paravalvular leakageP172Right ventricular dysfunction in patients with hypertrophic cardiomyopathyP173Interest of variations of echocardiographic parameters after initiation of specific therapy in the risk stratification of patients with pulmonary hypertensionP174Comparison of left and right atrial size and function in elite adolescent male football playersP175Do pocket-size imaging devices allow for reliable bedside vascular screening?P176Evolution of tricuspid regurgitation after pulmonary valve replacement for pulmonary regurgitation in repaired tetralogy of fallotP177Effect of perindopril/amlodipine combination on post-exercise E/e' in patients with arterial hypertensionP178Relationship between pulmonary venous flow and prosthetic mitral valve thrombosis P179Mitral valve parameters derived from 3-dimensional transesophageal echocardiography dataset: correlation between qlab and tomtec softwareP180Non-invasive pulmonary transit time: a new parameter for global cardiac performanceP181Assessment of the positive work and mechanical dispersion: new methods to quantify left ventricular function in aortic stenosisP182Atrial function in Takotsubo cardiomyopathy: deformation analysisP183Cardiac syndrome X- proven left ventricular perfusion and kinetic abnormalities by SPECT-CT and pharmacological dobutamine stress testP184Impact of frailty assessment on myocardial perfusion imaging results: a prospective cohort study. Eur Heart J Cardiovasc Imaging 2016. [DOI: 10.1093/ehjci/jew235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
124
|
Masuda M, Wakasaki T, Toh S, Kunitake N, Rikimaru F, Higaki Y. Utility of algorithm-based chemoradioselection for advanced laryngeal and hypopharyngeal carcinoma. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw376.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
125
|
Mizuk R, Bondar A, Adachi I, Aihara H, Asner DM, Atmacan H, Aulchenko V, Aushev T, Ayad R, Badhrees I, Bakich AM, Barberio E, Behera P, Bhardwaj V, Bhuyan B, Biswal J, Bobrov A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Danilov M, Dash N, Doležal Z, Drutskoy A, Eidelman S, Epifanov D, Ferber T, Fulsom BG, Gaur V, Garmash A, Gillard R, Goh YM, Goldenzweig P, Golob B, Greenwald D, Hara T, Hayasaka K, Hayashii H, Hou WS, Hsu CL, Inami K, Inguglia G, Ishikawa A, Iwasaki Y, Jaegle I, Julius T, Kang KH, Katrenko P, Kim DY, Kim HJ, Kim JB, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Kodyš P, Korpar S, Kotchetkov D, Krokovny P, Kuhr T, Kuzmin A, Kwon YJ, Lange JS, Li CH, Li H, Li L, Li Gioi L, Libby J, Liventsev D, Lubej M, Luo T, Masuda M, Matsuda T, Matvienko D, Miyabayashi K, Miyata H, Mohanty GB, Moll A, Nakano E, Nakao M, Nanut T, Nath KJ, Negishi K, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Olsen SL, Onuki Y, Pakhlov P, Pakhlova G, Pal B, Park CW, Park H, Paul S, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Pulvermacher C, Ritter M, Sakai Y, Sandilya S, Sanuki T, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Seino Y, Semmler D, Senyo K, Seon O, Sevior ME, Shebalin V, Shibata TA, Shiu JG, Shwartz B, Simon F, Solovieva E, Starič M, Stypula J, Sumiyoshi T, Takizawa M, Tamponi U, Tanida K, Teramoto Y, Tikhomirov I, Trabelsi K, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Usov Y, Van Hulse C, Varner G, Vorobyev V, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe Y, Williams KM, Won E, Yamaoka J, Yamashita Y, Yelton J, Yuan CZ, Zhang ZP, Zhilich V, Zhukova V, Zhulanov V, Zupanc A. Energy Scan of the e^{+}e^{-}→h_{b}(nP)π^{+}π^{-} (n=1, 2) Cross Sections and Evidence for ϒ(11020) Decays into Charged Bottomoniumlike States. PHYSICAL REVIEW LETTERS 2016; 117:142001. [PMID: 27740802 DOI: 10.1103/physrevlett.117.142001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2016] [Indexed: 06/06/2023]
Abstract
Using data collected with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider, we measure the energy dependence of the e^{+}e^{-}→h_{b}(nP)π^{+}π^{-} (n=1, 2) cross sections from thresholds up to 11.02 GeV. We find clear ϒ(10860) and ϒ(11020) peaks with little or no continuum contribution. We study the resonant substructure of the ϒ(11020)→h_{b}(nP)π^{+}π^{-} transitions and find evidence that they proceed entirely via the intermediate isovector states Z_{b}(10610) and Z_{b}(10650). The relative fraction of these states is loosely constrained by the current data: The hypothesis that only Z_{b}(10610) is produced is excluded at the level of 3.3 standard deviations, while the hypothesis that only Z_{b}(10650) is produced is not excluded at a significant level.
Collapse
|
126
|
Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, Kukimoto-Niino M, Moriyama H, Kashimoto S, Inoue T, Goto N, Okamoto K, Shirouzu M, Sawa M, Yamada T. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun 2016; 7:12586. [PMID: 27562646 PMCID: PMC5007443 DOI: 10.1038/ncomms12586] [Citation(s) in RCA: 105] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2016] [Accepted: 07/14/2016] [Indexed: 12/11/2022] Open
Abstract
Canonical Wnt/β-catenin signalling is essential for maintaining intestinal stem cells, and its constitutive activation has been implicated in colorectal carcinogenesis. We and others have previously identified Traf2- and Nck-interacting kinase (TNIK) as an essential regulatory component of the T-cell factor-4 and β-catenin transcriptional complex. Consistent with this, Tnik-deficient mice are resistant to azoxymethane-induced colon tumorigenesis, and Tnik−/−/Apcmin/+ mutant mice develop significantly fewer intestinal tumours. Here we report the first orally available small-molecule TNIK inhibitor, NCB-0846, having anti-Wnt activity. X-ray co-crystal structure analysis reveals that NCB-0846 binds to TNIK in an inactive conformation, and this binding mode seems to be essential for Wnt inhibition. NCB-0846 suppresses Wnt-driven intestinal tumorigenesis in Apcmin/+ mice and the sphere- and tumour-forming activities of colorectal cancer cells. TNIK is required for the tumour-initiating function of colorectal cancer stem cells. Its inhibition is a promising therapeutic approach. TRAF2 and NCK-interacting protein kinase (TNIK) is a key regulatory component of the TCF4 and β-catenin transcriptional complex. In this study, the authors identify a TNIK inhibitor that blocks Wnt signalling and Wnt-driven colorectal tumorigenesis in mice.
Collapse
|
127
|
Shiraki T, Iida O, Takahara M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Fujita M, Uematsu M. The Geriatric Nutritional Risk Index is Independently Associated with Prognosis in Patients with Critical Limb Ischemia Following Endovascular Therapy. Eur J Vasc Endovasc Surg 2016; 52:218-24. [DOI: 10.1016/j.ejvs.2016.05.016] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Accepted: 05/19/2016] [Indexed: 12/22/2022]
|
128
|
Yang SB, Tanida K, Kim BH, Adachi I, Aihara H, Asner DM, Aulchenko V, Aushev T, Babu V, Badhrees I, Bakich AM, Barberio E, Bhardwaj V, Bhuyan B, Biswal J, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Danilov M, Dash N, Doležal Z, Drásal Z, Dutta D, Eidelman S, Farhat H, Fast JE, Ferber T, Fulsom BG, Gabyshev N, Garmash A, Gaur V, Gillard R, Goh YM, Goldenzweig P, Greenwald D, Grygier J, Haba J, Hamer P, Hara T, Hayasaka K, Hayashii H, Hou WS, Iijima T, Inami K, Inguglia G, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Joo KK, Julius T, Kang KH, Kato E, Katrenko P, Kiesling C, Kim DY, Kim HJ, Kim JB, Kim KT, Kim MJ, Kim SH, Kim SK, Kim YJ, Kinoshita K, Kobayashi N, Kodyš P, Korpar S, Križan P, Krokovny P, Kuhr T, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li CH, Li H, Li L, Li Y, Li Gioi L, Libby J, Liventsev D, Lubej M, Masuda M, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Moon HK, Mussa R, Nakano E, Nakao M, Nanut T, Nath KJ, Nayak M, Negishi K, Niiyama M, Nisar NK, Nishida S, Ogawa S, Okuno S, Olsen SL, Pakhlova G, Pal B, Park CW, Park H, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Pulvermacher C, Rauch J, Ritter M, Rostomyan A, Ryu S, Sahoo H, Sakai Y, Sandilya S, Santelj L, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Schwartz AJ, Seino Y, Senyo K, Seon O, Seong IS, Sevior ME, Shebalin V, Shibata TA, Shiu JG, Shwartz B, Simon F, Sohn YS, Sokolov A, Stanič S, Starič M, Stypula J, Sumihama M, Sumiyoshi T, Takizawa M, Tamponi U, Teramoto Y, Trabelsi K, Trusov V, Uchida M, Uglov T, Unno Y, Uno S, Urquijo P, Usov Y, Vanhoefer P, Varner G, Varvell KE, Vinokurova A, Vossen A, Wagner MN, Wang CH, Wang MZ, Wang P, Wang XL, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Ye H, Yelton J, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. First Observation of the Doubly Cabibbo-Suppressed Decay of a Charmed Baryon: Λ_{c}^{+}→pK^{+}π^{-}. PHYSICAL REVIEW LETTERS 2016; 117:011801. [PMID: 27419562 DOI: 10.1103/physrevlett.117.011801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/24/2015] [Indexed: 06/06/2023]
Abstract
We report the first observation of the decay Λ_{c}^{+}→pK^{+}π^{-} using a 980 fb^{-1} data sample collected by the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. This is the first observation of a doubly Cabibbo-suppressed decay of a charmed baryon. We measure the branching ratio of this decay with respect to its Cabibbo-favored counterpart to be B(Λ_{c}^{+}→pK^{+}π^{-})/B(Λ_{c}^{+}→pK^{-}π^{+})=(2.35±0.27±0.21)×10^{-3}, where the uncertainties are statistical and systematic, respectively.
Collapse
|
129
|
Kondo H, Ishikawa M, Maeda H, Onuma M, Masuda M, Shibuya H, Koie H, Sato T. Spontaneous Osteosarcoma in a Rabbit (Oryctolagus cuniculus). Vet Pathol 2016; 44:691-4. [PMID: 17846243 DOI: 10.1354/vp.44-5-691] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
A 6-year-old male cross-breed rabbit ( Oryctolagus cuniculus) was presented with lameness and severe swelling from the right shoulder to brachium. On 16-detector helical computed tomography images of the amputated right forelimb after being fixed in formalin, evident proliferative and destructive lesions of bone were observed. On histologic examination, the tumor was composed of proliferating neoplastic cells that resembled histiocytes, with abundant osteoid production. A large number of multinucleated giant cells were found throughout. This case was diagnosed as osteosarcoma by clinical, radiographic, and histologic findings. This is a rare case report of osteosarcoma in a rabbit consistent with canine predilection sites.
Collapse
|
130
|
Garmash A, Abdesselam A, Adachi I, Aihara H, Asner DM, Aushev T, Ayad R, Aziz T, Babu V, Badhrees I, Bakich AM, Behera P, Bhardwaj V, Bhuyan B, Bobrov A, Bondar A, Bonvicini G, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Danilov M, Dash N, Doležal Z, Drutskoy A, Dutta D, Eidelman S, Epifanov D, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Gillard R, Goh YM, Goldenzweig P, Golob B, Hara T, Hayasaka K, Hayashii H, Iijima T, Ishikawa A, Itoh R, Iwasaki Y, Jaegle I, Joffe D, Joo KK, Julius T, Kang KH, Kato E, Kawasaki T, Kim DY, Kim JB, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Korpar S, Križan P, Krokovny P, Kuhr T, Kuzmin A, Kwon YJ, Lange JS, Lee IS, Li C, Li H, Li L, Li Gioi L, Libby J, Liventsev D, Lukin P, Masuda M, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Moll A, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Natkaniec Z, Nishida S, Olsen SL, Pakhlov P, Pakhlova G, Pal B, Park H, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Pulvermacher C, Ribežl E, Ritter M, Rostomyan A, Sahoo H, Sakai Y, Sandilya S, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Semmler D, Senyo K, Seong IS, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Shwartz B, Simon F, Sohn YS, Solovieva E, Starič M, Sumiyoshi T, Tamponi U, Tanida K, Teramoto Y, Trabelsi K, Uchida M, Uehara S, Uglov T, Uno S, Van Hulse C, Vanhoefer P, Varner G, Vorobyev V, Wagner MN, Wang CH, Wang MZ, Wang P, Watanabe Y, Williams KM, Won E, Yamamoto H, Yamaoka J, Yashchenko S, Yelton J, Yook Y, Yuan CZ, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Observation of Z_{b}(10610) and Z_{b}(10650) Decaying to B Mesons. PHYSICAL REVIEW LETTERS 2016; 116:212001. [PMID: 27284649 DOI: 10.1103/physrevlett.116.212001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/25/2015] [Indexed: 06/06/2023]
Abstract
We report the analysis of the three-body e^{+}e^{-}→BB[over ¯]π^{±}, BB[over ¯]^{*}π^{±}, and B^{*}B[over ¯]^{*}π^{±} processes, including the first observations of the Z_{b}^{±}(10610)→[BB[over ¯]^{*}+c.c.]^{±} and Z_{b}^{±}(10650)→[B^{*}B[over ¯]^{*}]^{±} transitions that are found to dominate the corresponding final states. We measure Born cross sections for the three-body production of σ(e^{+}e^{-}→[BB[over ¯]^{*}+c.c.]^{±}π^{∓})=[17.4±1.6(stat)±1.9(syst)] pb and σ(e^{+}e^{-}→[B^{*}B[over ¯]^{*}]^{±}π^{∓})=[8.75±1.15(stat)±1.04(syst)] pb and set a 90% C.L. upper limit of σ(e^{+}e^{-}→[BB[over ¯]]^{±}π^{∓})<2.9 pb. The results are based on a 121.4 fb^{-1} data sample collected with the Belle detector at a center-of-mass energy near the ϒ(10860) peak.
Collapse
|
131
|
Taniguchi T, Iizumi Y, Watanabe M, Masuda M, Morita M, Aono Y, Toriyama S, Oishi M, Goi W, Sakai T. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer. Cell Death Dis 2016; 7:e2211. [PMID: 27148684 PMCID: PMC4917653 DOI: 10.1038/cddis.2016.114] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2015] [Revised: 03/22/2016] [Accepted: 03/23/2016] [Indexed: 11/09/2022]
Abstract
Resveratrol has various attractive bioactivities, such as prevention of cancer, neurodegenerative disorders, and obesity-related diseases. Therefore, identifying its direct binding proteins is expected to discover druggable targets. Sirtuin 1 and phosphodiesterases have so far been found as the direct molecular targets of resveratrol. We herein identified 11 novel resveratrol-binding proteins, including the DEAD (Asp-Glu-Ala-Asp) box helicase 5 (DDX5, also known as p68), using resveratrol-immobilized beads. Treatment with resveratrol induced degradation of DDX5 in prostate cancer cells. Depletion of DDX5 caused apoptosis by inhibiting mammalian target of rapamycin complex 1 (mTORC1) signaling. Moreover, knockdown of DDX5 attenuated the inhibitory activities of resveratrol against mTORC1 signaling and cancer cell growth. These data show that resveratrol directly targets DDX5 and induces cancer cell death by inhibiting the mTORC1 pathway.
Collapse
|
132
|
Pal B, Schwartz AJ, Abdesselam A, Adachi I, Aihara H, Asner DM, Aushev T, Ayad R, Aziz T, Babu V, Badhrees I, Bahinipati S, Bakich AM, Barberio E, Behera P, Bhardwaj V, Bhuyan B, Biswal J, Bobrov A, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chistov R, Cho K, Chobanova V, Choi Y, Cinabro D, Dalseno J, Dash N, Doležal Z, Drásal Z, Drutskoy A, Dutta D, Eidelman S, Farhat H, Fast JE, Fulsom BG, Gaur V, Garmash A, Gillard R, Goh YM, Goldenzweig P, Greenwald D, Grzymkowska O, Haba J, Hara T, Hayasaka K, Hayashii H, He XH, Hou WS, Inami K, Ishikawa A, Iwasaki Y, Jacobs WW, Jaegle I, Jeon HB, Joffe D, Joo KK, Julius T, Kang KH, Kato E, Kawasaki T, Kiesling C, Kim DY, Kim HJ, Kim KT, Kim MJ, Kim SH, Kinoshita K, Kodyš P, Korpar S, Križan P, Krokovny P, Kuhr T, Kumar R, Kumita T, Kuzmin A, Kwon YJ, Lee IS, Li CH, Li H, Li L, Li Gioi L, Libby J, Liventsev D, Lukin P, Luo T, Masuda M, Matvienko D, Miyabayashi K, Miyata H, Mizuk R, Mohanty GB, Mohanty S, Moll A, Moon HK, Mori T, Mussa R, Nakano E, Nakao M, Nanut T, Natkaniec Z, Nayak M, Nisar NK, Nishida S, Ogawa S, Okuno S, Pakhlov P, Pakhlova G, Park CW, Park H, Paul S, Pedlar TK, Pesántez L, Pestotnik R, Petrič M, Piilonen LE, Pulvermacher C, Rauch J, Ribežl E, Ritter M, Rostomyan A, Ryu S, Sahoo H, Sakai Y, Sandilya S, Sanuki T, Sato Y, Savinov V, Schlüter T, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Seon O, Seong IS, Shebalin V, Shibata TA, Shiu JG, Shwartz B, Simon F, Sohn YS, Sokolov A, Solovieva E, Stanič S, Starič M, Stypula J, Sumihama M, Sumiyoshi T, Tamponi U, Teramoto Y, Trabelsi K, Uchida M, Uehara S, Uglov T, Uno S, Urquijo P, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Vinokurova A, Vossen A, Wagner MN, Wang CH, Wang MZ, Wang XL, Watanabe M, Watanabe Y, Williams KM, Won E, Yamaoka J, Yelton J, Yuan CZ, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Observation of the Decay B_{s}^{0}→K^{0}K[over ¯]^{0}. PHYSICAL REVIEW LETTERS 2016; 116:161801. [PMID: 27152790 DOI: 10.1103/physrevlett.116.161801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/07/2015] [Indexed: 06/05/2023]
Abstract
We measure the decay B_{s}^{0}→K^{0}K[over ¯]^{0} using data collected at the ϒ(5S) resonance with the Belle detector at the KEKB e^{+}e^{-} collider. The data sample used corresponds to an integrated luminosity of 121.4 fb^{-1}. We measure a branching fraction B(B_{s}^{0}→K^{0}K[over ¯]^{0})=[19.6_{-5.1}^{+5.8}(stat)±1.0(syst)±2.0(N_{B_{s}^{0}B[over ¯]_{s}^{0}})]×10^{-6} with a significance of 5.1 standard deviations. This measurement constitutes the first observation of this decay.
Collapse
|
133
|
Uno Y, Moriyama H, Kashimoto S, Masuda M, Sawa M, Yamada T. Abstract B17: Traf2- and NCK-interacting kinase (TNIK) inhibitor down-regulates Wnt signaling pathway in cancer cells. Mol Cancer Res 2016. [DOI: 10.1158/1557-3125.devbiolca15-b17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Aberrant activation of the Wnt signaling pathway has been implicated as the key driver of carcinogenesis, particularly in colorectal cancers. Because nearly 90% of colorectal cancers carry mutations either APC or β-catenin, downstream signaling molecules of the β-catenin destructive complex are considered as more attractive therapeutic targets in drug discovery research for the treatment of colorectal cancers. Recently, Traf2- and NCK-interacting kinase (TNIK) has been identified as one of components of the T-cell factor-4 (TCF4) transcriptional complex and essential for the expression of Wnt target genes. Knockdown of TNIK gene expression suppressed the transcriptional activity of the Wnt signaling pathway, and decreased in proliferation of colorectal cancer cells. Therefore inhibitors of TNIK may represent a promising therapeutic approach for treating Wnt-signal activated cancers. Previously we reported a thiazol-based TNIK inhibitor, N5355 have single digit nM IC50 value and the compound significantly down-regulated the Wnt target genes such as AXIN2 and cMYC in colorectal cancer cell line, HCT116. Further evaluations of N5355 have been implemented to characterize the effects of TNIK inhibition on cancer cell lines.
Methods: To study the effects of N5355 on the Wnt signaling pathway, the expression levels of Wnt target proteins were analyzed by Western blotting using Wnt-signal activated cancer cell lines. The ability of N5355 for blocking of nuclear translocation of phosphorylated TNIK was also analyzed by Western blotting using HCT116 cells. Anti-proliferative activity profile of N5355 was studied using a panel of 44 cancer cell lines. The pharmacokinetic profile of TNIK inhibitor was also analyzed.
Results: The Wnt signal inhibition was validated by significant suppression of Wnt target protein expressions by treating with N5355 in several cancer cells. In addition, Wnt co-receptor proteins LRP6 and LRP5 were found to be down-regulated by N5355 treatment. N5355 exhibited strong anti-proliferation activities against Wnt-driven cancer cell lines. Interestingly in DLD1 colorectal cancer cell lines, N5355 showed no anti-proliferative effect in conventional 2D cell culture assay, but displayed strong inhibitory activity in 3D cell culture assay using soft agar, which is biologically relevant assay system. The fact that N5355 inhibited the autophosphorylation of TNIK in the cytosol and subsequent nuclear translocation of TNIK in HCT116 cells suggested the depletion of TNIK proteins in nucleus resulted in the observed Wnt signal inhibition effect. Detailed results will be presented in the conference.
Citation Format: Yuko Uno, Hideki Moriyama, Shigeki Kashimoto, Mari Masuda, Masaaki Sawa, Tesshi Yamada. Traf2- and NCK-interacting kinase (TNIK) inhibitor down-regulates Wnt signaling pathway in cancer cells. [abstract]. In: Proceedings of the AACR Special Conference: Developmental Biology and Cancer; Nov 30-Dec 3, 2015; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(4_Suppl):Abstract nr B17.
Collapse
|
134
|
Miyanaga A, Masuda M, Tsuta K, Kawasaki K, Nakamura Y, Sakuma T, Asamura H, Gemma A, Yamada T. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 2016; 10:844-851. [PMID: 25902174 DOI: 10.1097/jto.0000000000000493] [Citation(s) in RCA: 77] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Malignant mesothelioma (MM) is an aggressive neoplasm causatively associated with exposure to asbestos. MM is rarely responsive to conventional cytotoxic drugs, and the outcome remains dismal. It is, therefore, necessary to identify the signaling pathways that drive MM and to develop new therapeutics specifically targeting the molecules involved. METHODS We performed comprehensive RNA sequencing of 12 MM cell lines and four clinical samples using so-called next-generation sequencers. RESULTS We found 15 novel fusion transcripts including one derived from chromosomal translocation between the large tumor suppressor 1 (LATS1) and presenilin-1 (PSEN1) genes. LATS1 is one of the central players of the emerging Hippo signaling pathway. The LATS1-PSEN1 fusion gene product lacked the ability to phosphorylate yes-associated protein and to suppress the growth of a MM cell line. The wild-type LATS1 allele was undetectable in this cell line, indicating two-hit genetic inactivation of its tumor suppressor function. Using pathway-targeted exon sequencing, we further identified a total of 11 somatic mutations in four Hippo pathway genes (neurofibromatosis type 2 [NF2], LATS2, RASSF1, and SAV1) in 35% (8 of 23) of clinical samples. Nuclear staining of yes-associated protein was detected in 55% (24 of 44) of the clinical samples. Expression and/or phosphorylation of the Hippo signaling proteins, RASSF1, Merlin (NF2), LATS1, and LATS2, was frequently absent. CONCLUSIONS The frequent alterations of Hippo pathway molecules found in this study indicate the therapeutic feasibility of targeting this pathway in patients with MM.
Collapse
|
135
|
Cho T, Tokunaga S, Izubuchi R, Masuda M. Confirmation of Intimal Tear in Thrombosed-Type Acute Aortic Dissection by Virtual Angioscopy. EJVES Short Rep 2016; 30:1-3. [PMID: 28856291 PMCID: PMC5573108 DOI: 10.1016/j.ejvssr.2015.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2015] [Revised: 11/26/2015] [Accepted: 12/05/2015] [Indexed: 11/25/2022] Open
Abstract
Introduction Therapeutic strategies for intramural hematoma (IMH) involving the ascending aorta remain controversial. Report The patient was a 72 year old woman with a history of chest pain. Multidetector computed tomography (MDCT) showed an IMH involving the ascending aorta. Because virtual angioscopy revealed a punctate intimal tear in the ascending aorta, acute aortic dissection with an intimal tear and not IMH was diagnosed, and emergency surgery was performed. The post-operative course was uneventful. Discussion Virtual angioscopy allows the vascular lumen to be examined minimally invasively on the basis of images reconstructed from MDCT data. Even if MDCT does not clearly show an intimal tear associated with aortic dissection in a general view, virtual angioscopy can show the exact location and size of the tear before surgery. Virtual angioscopy is very useful for distinguishing thrombosed-type acute aortic dissection without clear ulcer like projections from an IMH, which may facilitate therapeutic planning.
Collapse
|
136
|
Kameta N, Matsuzawa T, Yaoi K, Masuda M. Short polyethylene glycol chains densely bound to soft nanotube channels for inhibition of protein aggregation. RSC Adv 2016. [DOI: 10.1039/c6ra06793j] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Specific thermal dehydration/rehydration of short polyethylene glycol (PEG) chains densely bound to nanotube channels was useful for aggregation suppression and refolding acceleration of proteins.
Collapse
|
137
|
Masuda M, Sawa M, Yamada T. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. Pharmacol Ther 2015; 156:1-9. [DOI: 10.1016/j.pharmthera.2015.10.009] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
138
|
Chang YY, Wang MZ, Abdesselam A, Adachi I, Adamczyk K, Aihara H, Al Said S, Asner DM, Atmacan H, Aushev T, Babu V, Badhrees I, Bakich AM, Barberio E, Bhuyan B, Biswal J, Bobrov A, Bozek A, Bračko M, Browder TE, Červenkov D, Chekelian V, Chen A, Cheon BG, Chilikin K, Chistov R, Chobanova V, Choi SK, Choi Y, Cinabro D, Dalseno J, Danilov M, Dingfelder J, Doležal Z, Drásal Z, Dutta D, Eidelman S, Farhat H, Fast JE, Ferber T, Fulsom BG, Gaur V, Gabyshev N, Ganguly S, Garmash A, Gillard R, Glattauer R, Goh YM, Goldenzweig P, Greenwald D, Grzymkowska O, Haba J, Hayasaka K, Hayashii H, He XH, Hou WS, Hsu CL, Iijima T, Inami K, Ishikawa A, Itoh R, Iwasaki Y, Jacobs WW, Jaegle I, Joffe D, Joo KK, Kawasaki T, Kim DY, Kim HJ, Kim JB, Kim JH, Kim KT, Kim MJ, Kim SH, Kim YJ, Kinoshita K, Korpar S, Križan P, Krokovny P, Kuhr T, Kumita T, Kuzmin A, Kwon YJ, Lai YT, Lee IS, Li L, Li Y, Libby J, Liventsev D, Lukin P, Masuda M, Matvienko D, Miyabayashi K, Miyake H, Miyata H, Mizuk R, Mohanty GB, Mohanty S, Moll A, Moon HK, Mori T, Nakano E, Nakao M, Nanut T, Nayak M, Nishida S, Ogawa S, Ozaki H, Pakhlov P, Pakhlova G, Pal B, Park CW, Pedlar TK, Pestotnik R, Petrič M, Piilonen LE, Rauch J, Ribežl E, Ritter M, Rostomyan A, Ryu S, Sahoo H, Sakai Y, Sandilya S, Santelj L, Sanuki T, Savinov V, Schneider O, Schnell G, Schwanda C, Seino Y, Senyo K, Seong IS, Sevior ME, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simon F, Sohn YS, Starič M, Stypula J, Sumihama M, Sumisawa K, Sumiyoshi T, Tamponi U, Tanida K, Teramoto Y, Uglov T, Unno Y, Uno S, Usov Y, Van Hulse C, Vanhoefer P, Varner G, Vorobyev V, Vossen A, Wagner MN, Wang CH, Wang P, Watanabe M, Watanabe Y, Williams KM, Won E, Yamaoka J, Yashchenko S, Yelton J, Yusa Y, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. Observation of B^{0}→pΛ[over ¯]D^{(*)-}. PHYSICAL REVIEW LETTERS 2015; 115:221803. [PMID: 26650291 DOI: 10.1103/physrevlett.115.221803] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2015] [Indexed: 06/05/2023]
Abstract
We report the first observation of the decays B^{0}→pΛ[over ¯]D^{(*)-}. The data sample of 711 fb^{-1} used in this analysis corresponds to 772×10^{6} BB[over ¯] pairs, collected at the ϒ(4S) resonance by the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. We observe 19.8σ and 10.8σ excesses of events for the two decay modes and measure the branching fractions of B^{0}→pΛ[over ¯]D^{-} and B^{0}→pΛ[over ¯]D^{*-} to be (25.1±2.6±3.5)×10^{-6} and (33.6±6.3±4.4)×10^{-6}, respectively, where the first uncertainties are statistical and the second are systematic. These results are not compatible with the predictions based on the generalized factorization approach. In addition, a threshold enhancement in the dibaryon (pΛ[over ¯]) system is observed, consistent with that observed in similar B decays.
Collapse
|
139
|
Sugawara K, Ikaga T, Kim K, Ohkoshi Y, Okada K, Masunaga H, Kanaya T, Masuda M, Maeda Y. Fiber structure development in PS/PET sea-island conjugated fiber during continuous laser drawing. POLYMER 2015. [DOI: 10.1016/j.polymer.2015.10.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
140
|
Sawa M, Masuda M, Yamada T. Targeting the Wnt signaling pathway in colorectal cancer. Expert Opin Ther Targets 2015; 20:419-29. [PMID: 26439805 DOI: 10.1517/14728222.2016.1098619] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
INTRODUCTION The treatment of patients with advanced colorectal cancer still remains challenging, and identification of new target molecules and therapeutic avenues remains a priority. The great majority of colorectal cancers have mutations in one of two genes involved in the Wnt signaling pathway: the adenomatous polyposis coli (APC) and β-catenin (CTNNB1) genes. Up to now, however, no therapeutics for targeting this pathway have been established. AREAS COVERED This review article begins with a brief summary of Wnt signaling from the viewpoints of genetics, cancer stem cell biology, and drug development. We then overview current attempts to develop drugs directed at various components of the Wnt signaling pathway. EXPERT OPINION APC is a tumor suppressor, and therefore only downstream signal transducers of the APC protein can be considered as targets for pharmaceutical intervention. TRAF2 and NCK-interacting protein kinase (TNIK) was identified as the most downstream regulator of Wnt signaling by two independent research groups, and several classes of small-molecule inhibitors targeting this protein kinase have been developed. TNIK is a multifunctional protein with actions that extend beyond Wnt signaling regulation. Such TNIK inhibitors are expected to have a large variety of clinical applications.
Collapse
|
141
|
Abdesselam A, Adachi I, Adametz A, Adye T, Ahmed H, Aihara H, Akar S, Alam MS, Albert J, Al Said S, Andreassen R, Angelini C, Anulli F, Arinstein K, Arnaud N, Asner DM, Aston D, Aulchenko V, Aushev T, Ayad R, Babu V, Badhrees I, Bahinipati S, Bakich AM, Band HR, Banerjee S, Barberio E, Bard DJ, Barlow RJ, Batignani G, Beaulieu A, Bellis M, Ben-Haim E, Bernard D, Bernlochner FU, Bettarini S, Bettoni D, Bevan AJ, Bhardwaj V, Bhuyan B, Bianchi F, Biasini M, Biswal J, Blinov VE, Bloom PC, Bobrov A, Bomben M, Bondar A, Bonneaud GR, Bonvicini G, Bozek A, Bozzi C, Bračko M, Briand H, Browder TE, Brown DN, Brown DN, Bünger C, Burchat PR, Buzykaev AR, Calabrese R, Calcaterra A, Calderini G, Carpinelli M, Cartaro C, Casarosa G, Cenci R, Červenkov D, Chang P, Chao DS, Chauveau J, Cheaib R, Chekelian V, Chen A, Chen C, Cheng CH, Cheon BG, Chilikin K, Chistov R, Cho K, Chobanova V, Choi HHF, Choi SK, Chrzaszcz M, Cibinetto G, Cinabro D, Cochran J, Coleman JP, Contri R, Convery MR, Cowan G, Cowan R, Cremaldi L, Dalseno J, Dasu S, Davier M, Davis CL, De Mori F, De Nardo G, Denig AG, Derkach D, de Sangro R, Dey B, Di Lodovico F, Dingfelder J, Dittrich S, Doležal Z, Dorfan J, Drásal Z, Drutskoy A, Druzhinin VP, Dubois-Felsmann GP, Dunwoodie W, Dutta D, Ebert M, Echenard B, Eidelman S, Eigen G, Eisner AM, Emery S, Ernst JA, Faccini R, Farhat H, Fast JE, Feindt M, Ferber T, Ferrarotto F, Ferroni F, Field RC, Filippi A, Finocchiaro G, Fioravanti E, Flood KT, Ford WT, Forti F, Franco Sevilla M, Fritsch M, Fry JR, Fulsom BG, Gabathuler E, Gabyshev N, Gamba D, Garmash A, Gary JW, Garzia I, Gaspero M, Gaur V, Gaz A, Gershon TJ, Getzkow D, Gillard R, Li Gioi L, Giorgi MA, Glattauer R, Godang R, Goh YM, Goldenzweig P, Golob B, Golubev VB, Gorodeisky R, Gradl W, Graham MT, Grauges E, Griessinger K, Gritsan AV, Grosdidier G, Grünberg O, Guttman N, Haba J, Hafner A, Hamilton B, Hara T, Harrison PF, Hast C, Hayasaka K, Hayashii H, Hearty C, He XH, Hess M, Hitlin DG, Hong TM, Honscheid K, Hou WS, Hsiung YB, Huard Z, Hutchcroft DE, Iijima T, Inguglia G, Innes WR, Ishikawa A, Itoh R, Iwasaki Y, Izen JM, Jaegle I, Jawahery A, Jessop CP, Joffe D, Joo KK, Julius T, Kang KH, Kass R, Kawasaki T, Kerth LT, Khan A, Kiesling C, Kim DY, Kim JB, Kim JH, Kim KT, Kim P, Kim SH, Kim YJ, King GJ, Kinoshita K, Ko BR, Koch H, Kodyš P, Kolomensky YG, Korpar S, Kovalskyi D, Kowalewski R, Kravchenko EA, Križan P, Krokovny P, Kuhr T, Kumar R, Kuzmin A, Kwon YJ, Lacker HM, Lafferty GD, Lanceri L, Lange DJ, Lankford AJ, Latham TE, Leddig T, Le Diberder F, Lee DH, Lee IS, Lee MJ, Lees JP, Leith DWGS, Leruste P, Lewczuk MJ, Lewis P, Libby J, Lockman WS, Long O, Lopes Pegna D, LoSecco JM, Lou XC, Lueck T, Luitz S, Lukin P, Luppi E, Lusiani A, Luth V, Lutz AM, Lynch G, MacFarlane DB, Malaescu B, Mallik U, Manoni E, Marchiori G, Margoni M, Martellotti S, Martinez-Vidal F, Masuda M, Mattison TS, Matvienko D, McKenna JA, Meadows BT, Miyabayashi K, Miyashita TS, Miyata H, Mizuk R, Mohanty GB, Moll A, Monge MR, Moon HK, Morandin M, Muller DR, Mussa R, Nakano E, Nakazawa H, Nakao M, Nanut T, Nayak M, Neal H, Neri N, Nisar NK, Nishida S, Nugent IM, Oberhof B, Ocariz J, Ogawa S, Okuno S, Olaiya EO, Olsen J, Ongmongkolkul P, Onorato G, Onuchin AP, Onuki Y, Ostrowicz W, Oyanguren A, Pakhlova G, Pakhlov P, Palano A, Pal B, Palombo F, Pan Y, Panduro Vazquez W, Paoloni E, Park CW, Park H, Passaggio S, Patel PM, Patrignani C, Patteri P, Payne DJ, Pedlar TK, Peimer DR, Peruzzi IM, Pesántez L, Pestotnik R, Petrič M, Piccolo M, Piemontese L, Piilonen LE, Pilloni A, Piredda G, Playfer S, Poireau V, Porter FC, Posocco M, Prasad V, Prell S, Prepost R, Puccio EMT, Pulliam T, Purohit MV, Pushpawela BG, Rama M, Randle-Conde A, Ratcliff BN, Raven G, Ribežl E, Richman JD, Ritchie JL, Rizzo G, Roberts DA, Robertson SH, Röhrken M, Roney JM, Roodman A, Rossi A, Rostomyan A, Rotondo M, Roudeau P, Sacco R, Sakai Y, Sandilya S, Santelj L, Santoro V, Sanuki T, Sato Y, Savinov V, Schindler RH, Schneider O, Schnell G, Schroeder T, Schubert KR, Schumm BA, Schwanda C, Schwartz AJ, Schwitters RF, Sciacca C, Seiden A, Sekula SJ, Senyo K, Seon O, Serednyakov SI, Sevior ME, Shapkin M, Shebalin V, Shen CP, Shibata TA, Shiu JG, Simard M, Simi G, Simon F, Simonetto F, Skovpen YI, Smith AJS, Smith JG, Snyder A, So RY, Sobie RJ, Soffer A, Sohn YS, Sokoloff MD, Sokolov A, Solodov EP, Solovieva E, Spaan B, Spanier SM, Starič M, Stocchi A, Stroili R, Stugu B, Su D, Sullivan MK, Sumihama M, Sumisawa K, Sumiyoshi T, Summers DJ, Sun L, Tamponi U, Taras P, Tasneem N, Teramoto Y, Tisserand V, Todyshev KY, Toki WH, Touramanis C, Trabelsi K, Tsuboyama T, Uchida M, Uglov T, Unno Y, Uno S, Usov Y, Uwer U, Vahsen SE, Van Hulse C, Vanhoefer P, Varner G, Vasseur G, Va'vra J, Verderi M, Vinokurova A, Vitale L, Vorobyev V, Voß C, Wagner MN, Wagner SR, Waldi R, Walsh JJ, Wang CH, Wang MZ, Wang P, Watanabe Y, West CA, Williams KM, Wilson FF, Wilson JR, Wisniewski WJ, Won E, Wormser G, Wright DM, Wu SL, Wulsin HW, Yamamoto H, Yamaoka J, Yashchenko S, Yuan CZ, Yusa Y, Zallo A, Zhang CC, Zhang ZP, Zhilich V, Zhulanov V, Zupanc A. First Observation of CP Violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} Decays by a Combined Time-Dependent Analysis of BABAR and Belle Data. PHYSICAL REVIEW LETTERS 2015; 115:121604. [PMID: 26430984 DOI: 10.1103/physrevlett.115.121604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Indexed: 06/05/2023]
Abstract
We report a measurement of the time-dependent CP asymmetry of B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays, where the light neutral hadron h^{0} is a π^{0}, η, or ω meson, and the neutral D meson is reconstructed in the CP eigenstates K^{+}K^{-}, K_{S}^{0}π^{0}, or K_{S}^{0}ω. The measurement is performed combining the final data samples collected at the ϒ(4S) resonance by the BABAR and Belle experiments at the asymmetric-energy B factories PEP-II at SLAC and KEKB at KEK, respectively. The data samples contain (471±3)×10^{6} BB[over ¯] pairs recorded by the BABAR detector and (772±11)×10^{6} BB[over ¯] pairs recorded by the Belle detector. We measure the CP asymmetry parameters -η_{f}S=+0.66±0.10(stat)±0.06(syst) and C=-0.02±0.07(stat)±0.03(syst). These results correspond to the first observation of CP violation in B[over ¯]^{0}→D_{CP}^{(*)}h^{0} decays. The hypothesis of no mixing-induced CP violation is excluded in these decays at the level of 5.4 standard deviations.
Collapse
|
142
|
Yamanaka-Okumura H, Hirayama A, Wada S, Kajiura D, Masuda M, Takeda E, Taketani Y, Imura S, Utsunomiya T, Shimada M, Tomita M, Soga T. MON-PP050: Perioperative Serum and Urine Metabolome Analysis in Patients with Hepatocellular Carcinoma. Clin Nutr 2015. [DOI: 10.1016/s0261-5614(15)30482-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
143
|
Nonaka L, Maruyama F, Suzuki S, Masuda M. Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site. Lett Appl Microbiol 2015; 61:1-6. [PMID: 25765542 DOI: 10.1111/lam.12414] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2014] [Revised: 02/25/2015] [Accepted: 03/09/2015] [Indexed: 01/10/2023]
Abstract
UNLABELLED The aim of this study was to determine whether mef(C) and mph(G), originally found on the transferable multi-drug plasmid pAQU1 from Photobacterium damselae subsp. damselae isolated from seawater of a fish farm, are responsible for conferring macrolide resistance. Since these genes are localized head-to-tail on pAQU1 and only four nucleotides exist between them, the single- and combination-effect of these genes was examined. When mph(G) alone was introduced to Escherichia coli, the minimum inhibitory concentrations (MICs) against erythromycin, clarithromycin and azithromycin increased, whereas introduction of mef(C) alone did not influence macrolide susceptibility. Introduction of both mef(C) and mph(G) dramatically increased the MICs to the same three macrolides, i.e. >512 μg ml(-1) , >512 μg ml(-1) and 128 μg ml(-1) respectively. These results suggest that the macrolide phosphotransferase encoded by mph(G) is essential for macrolide resistance, while the efflux pump encoded by mef(C) is required for high-level macrolide resistance. The tandem-pair arrangements of the mef(C) and mph(G) genes were conserved on plasmids ranging in size from 240 to 350 kb of the 22 erythromycin-resistant strains belonging to Vibrio and Photobacterium obtained from the fish farm. Sixteen of 22 plasmids ranged in size from 300 to 350 kb. This is the first report of novel macrolide resistance genes originating from a marine bacterium. SIGNIFICANCE AND IMPACT OF THE STUDY In this study, mef(C) and mph(G) were found to be novel macrolide-resistance genes, and this is the first report of macrolide-resistance genes originating from a marine bacterium. These genes may be responsible for previously reported cases of the emergence of erythromycin-resistant bacteria in aquaculture sites by an unknown mechanism. The introduction of the tandem arrangement of the mef(C) and mph(G) genes in Escherichia coli increased the MICs to erythromycin, clarithromycin and azithromycin, suggesting a novel mechanism conferring high-level macrolide resistance via combined expression of the efflux pump and macrolide phosphotransferase.
Collapse
|
144
|
Otani T, Ogata S, Miwa M, Takeuchi Y, Masuda M, Takasugi J, Naka T, Ota M. Characteristics of joint movement during the motion of rising from a supine position. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.2073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
145
|
Fujikawa H, Sakamaki K, Kawabe T, Hayashi T, Aoyama T, Sato T, Oshima T, Rino Y, Morita S, Masuda M, Ogata T, Cho H, Yoshikawa T. A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment. Ann Surg Oncol 2015; 22:2317-22. [PMID: 25752893 DOI: 10.1245/s10434-015-4474-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2014] [Indexed: 11/18/2022]
Abstract
BACKGROUND Clinical T1 gastric cancer has low metastatic potential to lymph nodes and is generally curable by local treatment. Endoscopic resection can preserve the whole stomach and does not impair the patient's quality of life; however, its indication is strictly limited to the subset of patients without nodal metastasis. The study was designed to predict reliably the patients without nodal metastasis based only on the clinical information. METHODS We examined patients with clinical T1 disease who were treated with surgery. The clinically available information was evaluated for its ability to predict nodal metastasis by logistic regression model. Then, the predictive ability of the logistic regression model using the risk factors for nodal metastasis was evaluated by a receiver operating characteristic curve. RESULTS A total of 511 patients were entered into this study. The clinical depth (cT1a or cT1b), maximal tumor diameter, and pathological type were confirmed to be significantly different between patients with and without nodal metastasis. The cutoff value of the tumor diameter differed depending on the histology and clinical depth: 79 mm for differentiated type and 48 mm for undifferentiated type in cT1a tumors, and 43 mm for differentiated type and 11 mm for undifferentiated type in cT1b tumors. According to these criteria, 348 of the 511 patients (68.1 %) were classified to have predictive N0 status. The negative predictive value was 95.7 % (95 % confidence interval 94.0-97.5 %). CONCLUSIONS The predictive criteria based on the multivariate logistic model identified that almost two-thirds of the patients with clinical T1 gastric cancer were possible candidates for endoscopic treatment.
Collapse
|
146
|
Thomas R, Schmidt H, Gatchell M, Rosén S, Reinhed P, Löfgren P, Brännholm L, Blom M, Björkhage M, Bäckström E, Alexander J, Leontein S, Hanstorp D, Zettergren H, Kaminska M, Nascimento R, Liljeby L, Källberg A, Simonsson A, Hellberg F, Mannervik S, Larsson M, Geppert W, Rensfelt K, Paál A, Masuda M, Halldén P, Andler G, Stockett M, Chen T, Källersjö G, Weimer J, Hansen K, Hartman H, Cederquist H. DESIREE: Physics with cold stored ion beams. EPJ WEB OF CONFERENCES 2015. [DOI: 10.1051/epjconf/20158401004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
147
|
Kovacs A, Assabiny A, Lakatos B, Apor A, Nagy A, Kutyifa V, Merkely B, Ulbrich S, Sveric K, Rady M, Strasser R, Ebner B, Lervik Nilsen LC, Brekke B, Missant C, Ortega A, Haemers P, Tong L, Sutherland G, D'hooge J, Stoylen A, Gurzun MM, Ionescu A, Santoro A, Federico Alvino F, Carlo Gaetano Sassi C, Giovanni Antonelli G, Sergio Mondillo S, Chumarnaya T, Alueva Y, Kochmasheva V, Mikhailov S, Ostern O, Solovyova O, Revishvili A, Markhasin V, Rodriguez Munoz D, Carbonell Sanroman A, Moya Mur J, Fernandez Santos S, Lazaro Rivera C, Valverde Gomez M, Casas Rojo E, Garcia Martin A, Fernandez-Golfin C, Zamorano Gomez J, Kanda T, Fujita M, Masuda M, Iida O, Okamoto S, Ishihara T, Nanto K, Shiraki T, Takahara M, Uematsu M, Kolesnyk MY, Victor K, Lux D, Carr-White G, Barrett N, Glover G, Langrish C, Meadows C, Ioannou N, Castaldi B, Vida V, Argiolas A, Maschietto N, Cerutti A, Biffanti R, Reffo E, Padalino M, Stellin G, Milanesi O, Simova I, Katova T, Galderisi M, Lalov I, Onciul S, Alexandrescu A, Petre I, Zamfir D, Onut R, Tautu O, Dorobantu M, Caldas A, Ladeia A, D'almeida J, Guimaraes A, Ball C, Abdelmoneim Mohamed S, Huang R, Zysek V, Mantovani F, Scott C, Mccully R, Mulvagh S, Lee JH, Cho G, Mihaila S, Muraru D, Aruta P, Piasentini E, Cavalli G, Ucci L, Peluso D, Vinereanu D, Iliceto S, Badano L, Ozawa K, Funabashi N, Takaoka H, Kamata T, Nomura F, Kobayashi Y, Ovsianas J, Valuckiene Z, Mizariene V, Jurkevicius R, Reskovic Luksic V, Dosen D, Cekovic S, Separovic Hanzevacki J, Simova I, Katova T, Santoro C, Galderisi M, Kalcik M, Cakal B, Gursoy M, Astarcioglu M, Yesin M, Gunduz S, Karakoyun S, Cersit S, Toprak C, Ozkan M. Club 35 Poster session 3: Friday 5 December 2014, 08:30-18:00 * Location: Poster area. Eur Heart J Cardiovasc Imaging 2014. [DOI: 10.1093/ehjci/jeu263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
148
|
Uno Y, Moriyama H, Kashimoto S, Masuda M, Sawa M, Yamada T. 346 Inhibition of Wnt pathway by novel thiazole-based Traf2- and Nck-interacting kinase (TNIK) inhibitor. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70472-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
149
|
Masuda M, Yamada T. Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2014; 1854:651-7. [PMID: 25448010 DOI: 10.1016/j.bbapap.2014.10.014] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2014] [Revised: 10/01/2014] [Accepted: 10/20/2014] [Indexed: 11/28/2022]
Abstract
Deregulation of intracellular signaling through accumulation of genetic alterations is a hallmark of cancer. In the past few decades, concerted and systematic efforts have been made to identify key genetic alterations and to develop therapeutic agents targeting active signaling molecules. However, the efficacy of molecular therapeutics often varies among individuals, and precise mapping of active molecules in individual patients is now considered an essential for therapy optimization. Reverse-phase protein array or microarray (RPPA or RPPM) is an emerging antibody-based highly quantitative proteomic technology, especially suitable for profiling of expression and modification of signaling proteins in low abundance. Because the supply of clinical materials is often limited, RPPA technology is highly advantageous for clinical proteomics in view of its high sensitivity as well as accurate quantification. RPPA has now begun to be incorporated into various clinical trials employing molecular-targeted therapeutics. In this article we review and discuss the application of RPPA technology in the fields of basic, preclinical, and clinical research. The RPPA Global Workshop was recently launched to accelerate the exchange of rapidly expanding knowledge of this fascinating technology among academic laboratories and industries worldwide. This article is part of a Special Issue entitled: Medical Proteomics.
Collapse
|
150
|
Miyanaga A, Masuda M, Tsuta K, Nakamura Y, Asamura H, Gemma A, Yamada T. Abstract 4679: Novel pathway mutations in malignant mesothelioma revealed by high-throughput DNA and RNA sequencing. Cancer Res 2014. [DOI: 10.1158/1538-7445.am2014-4679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Malignant mesothelioma (MM) is an aggressive neoplasm associated with asbestos exposure. Because MM is usually diagnosed at an advanced stage and is largely unresponsive to conventional therapy, it is necessary to identify the signal pathways driving MM and to develop therapeutics specifically targeting these pathways.
Materials and Methods: We carried out RNA sequencing of 12 MM cell lines and 4 clinical samples and exome sequencing of 6 MM cells using a so-called next-generation sequencer. We further performed pathway-targeted genome sequencing of 23 paired samples of MM tumor and normal tissue.
Results: We identified 15 novel fusion genes by RNA sequencing and confirmed them by conventional Sanger sequencing and FISH analyses. We showed that the novel gene was included in both LOH and a fusion gene, and the gene which was critical tumor-suppressor roles caused two hit and was down-regulated. The gene has been identified as a central player of the emerging signaling pathway. We further identified the accumulation of mutations in 35% of the MMs by pathway-targeted genome sequencing.
Conclusions: We indicated the need for the discovering molecular targets in the novel pathway in MMs. Our findings provide novel insights into the pathogenesis of MM and unequivocally demonstrate the power of sequencing technologies in cancer research.
Citation Format: Akihiko Miyanaga, Mari Masuda, Koji Tsuta, Yuka Nakamura, Hisao Asamura, Akihiko Gemma, Tesshi Yamada. Novel pathway mutations in malignant mesothelioma revealed by high-throughput DNA and RNA sequencing. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4679. doi:10.1158/1538-7445.AM2014-4679
Collapse
|